The informal use of antiretroviral medications for HIV prevention by men who have sex with men in South Florida: initiation, use practices, medications and motivations

References

• Adams, Joëlla W., J. Shinefeld, and Kathleen A. Brady. 2016. “Acceptability of Oral Preexposure Prophylaxis among Men Who Have Sex with Men in Philadelphia.” JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (3): e62–e65.
   PubMed Web of Science ®Google Scholar
• Auerbach, Judith D., and Trevor A. Hoppe. 2015. “Beyond ‘Getting Drugs into Bodies’: Social Science Perspectives on Pre-Exposure Prophylaxis for HIV.” Journal of the International AIDS Society 18 (Supplement 3): 19983.
   PubMed Web of Science ®Google Scholar
• Barbour, Rosaline S. 2001. “Checklists for Improving Rigour in Qualitative Research: A Case of the Tail Wagging the Dog?” British Medical Journal 322 (7294): 1115–1117.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2014. Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014: A Clinical Practice Guideline. U.S. Department of Health and Human Services. http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
   Google Scholar
• Colorafi, Karen J., and B. Evans. 2016. “Qualitative Descriptive Methods in Health Science Research.” HERD: Health Environments Research & Design Journal 9 (4): 16–25.
   Web of Science ®Google Scholar
• Dimitrov, D., M.-C. Boily, Benoît R. Mȃsse, and Elizabeth R. Brown. 2012. “Impact of Pill Sharing on Drug Resistance due to a Wide-Scale Oral PrEP Intervention in Generalized Epidemics.” Journal of AIDS and Clinical Research Supplement 5 (4): S5–004.
   PubMedGoogle Scholar
• Eaton, Lisa A., Seth C. Kalichman, D. Price, S. Finneran, A. Allen, and J. Maksut. 2017. “Stigma and Conspiracy Beliefs Related to Pre-Exposure Prophylaxis (PrEP) and Interest in Using PrEP among Black and White Men and Transgender Women Who Have Sex with Men.” AIDS & Behavior 21 (5): 1236–1246.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. 2012. "Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use." www.fda.gov/downloads/newsevents/newsroom/factsheets/ucm312279.pdf
   Google Scholar
• Grant, Robert M., Peter L. Anderson, V. McMahan, A. Liu, K. R. Amico, M. Mehrotra, S. Hosek, et al. 2014. “Uptake of Pre-Exposure Prophylaxis, Sexual Practices, and HIV Incidence in Men and Transgender Women Who Have Sex with Men: A Cohort Study.” The Lancet Infectious Diseases 14 (9): 820–829.
   PubMed Web of Science ®Google Scholar
• Günthard, Huldrych F., Michael S. Saag, Constance A. Benson, C. del Rio, Joseph J. Eron, Joel E. Gallant, Jennifer F. Hoy, et al. 2016. “Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel.” JAMA 316 (2): 191–210.
   PubMed Web of Science ®Google Scholar
• Hood, Julia E., Susan E. Buskin, Julia C. Dombrowski, David A. Kern, Elizabeth A. Barash, David A. Katzi, and Matthew R. Golden. 2016. “Dramatic Increase in Preexposure Prophylaxis Use among MSM in Washington State.” AIDS 30 (3): 515–519.
   PubMed Web of Science ®Google Scholar
• Inciardi, James A., Hilary L. Surratt, Steven P. Kurtz, and John J. Burke. 2006. “The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio.” Substance Use and Misuse 41 (2): 255–264.
   PubMed Web of Science ®Google Scholar
• Kippax, S. 2012. “Effective HIV Prevention: The Indispensable Role of Social Science.” Journal of the International AIDS Society 15 (2): 17357.
   PubMed Web of Science ®Google Scholar
• Kippax, S., and N. Stephenson. 2012. “Beyond the Distinction between Biomedical and Social Dimensions of HIV Prevention through the Lens of a Social Public Health.” American Journal of Public Health 102 (5): 789–799.
   PubMed Web of Science ®Google Scholar
• Koenig, Linda J., C. Lyles, and Dawn K. Smith. 2013. “Adherence to Antiretroviral Medications for HIV Pre-Exposure Prophylaxis: Lessons Learned from Trials and Treatment Studies.” American Journal of Preventive Medicine 44 (1): S91–S98.
   PubMed Web of Science ®Google Scholar
• Kurtz, Steven P., and Mance E. Buttram. 2016. “Misunderstanding of Pre-Exposure Prophylaxis Use among MSM: Public Health and Policy Implications.” LGBT Health 3 (6): 461–464.
   PubMed Web of Science ®Google Scholar
• Kurtz, Steven P., Mance E. Buttram, and Hilary L. Surratt. 2014. “Vulnerable Infected Populations and Street Markets for ARVs: Potential Implications for PrEP Rollout in the US.” AIDS Care 26 (4): 411–415.
   PubMed Web of Science ®Google Scholar
• Liu, Albert Y., Pravina V. Kittredge, E. Vittinghoff, H. F. Raymond, K. Ahrens, T. Matheson, J. Hecht, Jeffrey D. Klausner, and Susan P. Buchbinder. 2008. “Limited Knowledge and Use of HIV Post- and Pre-Exposure Prophylaxis among Gay and Bisexual Men.” JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (2): 241–247.
   PubMed Web of Science ®Google Scholar
• Mansergh, G., B. A. Koblin, G. N. Colfax, D. J. McKirnan, S. A. Flores, and S. M. Hudson. 2010. “Preefficacy Use and Sharing of Antiretroviral Medications to Prevent Sexually-Transmitted HIV Infection among US Men Who Have Sex with Men.” JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2): e14–e16.
   PubMed Web of Science ®Google Scholar
• McCormack, S., D. T. Dunn, M. Desai, D. I. Dolling, M. Gafos, R. Gilson, A. K. Sullivan, et al. 2016. “Pre-Exposure Prophylaxis to Prevent the Acquisition of HIV-1 Infection (PROUD): Effectiveness Results from the Pilot Phase of a Pragmatic Open-Label Randomised Trial.” The Lancet 387 (10013): 53–60.
   PubMed Web of Science ®Google Scholar
• Mimiaga, Matthew J., P. Case, Carey V. Johnson, Steven A. Safren, and Kenneth H. Mayer. 2009. “Pre-Exposure Antiretroviral Prophylaxis (PrEP) Attitudes in High-Risk Boston Area Men Who Report Having Sex with Men: Limited Knowledge and Experience, but Potential for Increased Utilization after Education.” JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (1): 77–83.
   PubMed Web of Science ®Google Scholar
• Molina, J. M., C. Capitant, B. Spire, G. Pialoux, L. Cotte, I. Charreau, C. Tremblay, et al. 2015. “On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.” New England Journal of Medicine 373 (23): 2237–2246.
   PubMed Web of Science ®Google Scholar
• Saldaña, J. 2013. The Coding Manual for Qualitative Researchers. Los Angeles, CA: SAGE.
   Google Scholar
• Smith, D. K., R. M. Grant, P. J. Weidle, A. Lansky, J. Mermin, and K. A. Fenton. 2011. “Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men.” MMWR Morbidity and Mortality Weekly Report 60 (3): 65–68.
   PubMedGoogle Scholar
• Surratt, H. L., S. P. Kurtz, T. J. Cicero, C. O'Grady, and M. A. Levi-Minzi. 2013. “Antiretroviral Medication Diversion among HIV-Positive Substance Abusers in South Florida.” American Journal of Public Health 103 (6): 1026–1028.
   PubMed Web of Science ®Google Scholar
• Thomann, M., A. Grosso, R. Zapata, and Mary A. Chiasson. 2017. “‘WTF is PrEP?’: Attitudes towards Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in New York City.” Culture, Health & Sexuality. Advance online publication. doi:10.1080/13691058.2017.1380230
   PubMed Web of Science ®Google Scholar
• Voetsch, Andrew C., James D. Heffelfinger, Elin B. Begley, K. Jafa-Bhushan, and Patrick S. Sullivan. 2007. “Knowledge and Use of Preexposure and Postexposure Prophylaxis among Attendees of Minority Gay Pride Events, 2005 through 2006.” JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (3): 378–380.
   PubMed Web of Science ®Google Scholar
• Weber, J., R. Tatoud, and S. Fidler. 2010. “Postexposure Prophylaxis, Preexposure Prophylaxis or Universal Test and Treat: The Strategic Use of Antiretroviral Drugs to Prevent HIV Acquisition and Transmission.” AIDS 24 (suppl 4): S27–S39.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2014. Consolodated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. Geneva, Switzerland: World Health Organization. http://www.who.int/hiv/pub/toolkits/keypopulations/en/
   Google Scholar
• Wu, H., Maria C. B. Mendoza, Ya-lin A. Huang, T. Hayes, Dawn K. Smith, and Karen W. Hoover. 2017. “Uptake of HIV Preexposure Prophylaxis among Commercially Insured Persons – United States, 2010–2014.” Clinical Infectious Diseases 64 (2): 144–149.
   PubMed Web of Science ®Google Scholar